Sat Kartar Life Limited Receives NSE In-Principle Approval for Equity Share Issuance via Warrant Conversion
Sat Kartar Life Limited has received NSE in-principle approval under Regulation 28(1) of SEBI (LODR) Regulations, 2015, for the issuance of 50,400 equity shares and 27,74,400 equity shares of Rs. 10/- each, to be allotted upon conversion of warrants issued through a preferential issue. The approval was granted vide NSE letter Ref. No. NSE/LIST/54702 dated May 08, 2026, following the company's application submitted on April 21, 2026. The approval is conditional upon the company meeting several regulatory, statutory, and compliance requirements, including strengthening internal controls over allottee trading activity. The NSE has reserved the right to withdraw the approval if any submitted information is found to be incomplete, incorrect, or in violation of applicable rules.

*this image is generated using AI for illustrative purposes only.
Sat Kartar Life Limited (formerly known as Sat Kartar Shopping Limited) has received in-principle approval from the National Stock Exchange of India Limited (NSE) for the issuance of equity shares pursuant to the conversion of warrants through a preferential issue. The approval was communicated vide NSE letter bearing Ref. No. NSE/LIST/54702 dated May 08, 2026, under Regulation 28(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company had submitted its application to NSE on April 21, 2026, seeking this approval.
Details of the Approved Share Issuance
The in-principle approval covers two tranches of equity shares to be allotted upon conversion of warrants issued through a preferential issue. The key details of the approved issuance are as follows:
| Parameter: | Details |
|---|---|
| Approval Reference: | NSE/LIST/54702 |
| Approval Date: | May 08, 2026 |
| Tranche 1 – Equity Shares: | 50,400 shares of Rs. 10/- each |
| Tranche 2 – Equity Shares: | 27,74,400 shares of Rs. 10/- each |
| Face Value: | Rs. 10/- per share |
| Mode of Issuance: | Conversion of warrants via preferential issue |
| Regulatory Framework: | Regulation 28(1) of SEBI (LODR) Regulations, 2015 |
Conditions Attached to the Approval
The NSE has granted the in-principle approval subject to the company fulfilling a set of regulatory and procedural conditions. These conditions must be met before the final listing of the shares is permitted.
- Filing the listing application at the earliest from the date of allotment
- Receipt of statutory and other approvals, and compliance with guidelines and regulations issued by statutory authorities including SEBI, RBI, and MCA
- Compliance with all applicable guidelines, regulations, and directions of the Exchange or any statutory authorities as on the date of the listing application
- Compliance with all conditions as per the SEBI (LODR) Regulations, 2015, Companies Act, 1956/Companies Act, 2013, and other applicable laws
- Submission of documents as may be required by NSE and payment of applicable fees
Internal Controls and Allottee Compliance Advisory
The NSE has also advised the company to strengthen internal controls to monitor trades executed by the proposed allottees in the company's scrip prior to allotment. Specifically, the exchange has directed the company to obtain an undertaking from the allottee(s) confirming that they shall not engage in intra-day trading or any sale in the company's scrip until the allotment date, as required under SEBI (ICDR) Regulations. The responsibility and onus to verify and ensure such compliance, including adherence to Regulation 167(6) of SEBI ICDR Regulations, 2018, rests solely with the issuer company. The NSE has further noted that any non-compliances observed post the undertaking and verification by the issuer company may impact the listing of such shares.
Exchange's Right of Withdrawal
The NSE has explicitly reserved its right to withdraw the in-principle approval at a later stage if the information submitted to the exchange is found to be incomplete, incorrect, misleading, or false, or if it is in contravention of any Rules, Bye-laws, and Regulations of the Exchange, SEBI (LODR) Regulations, 2015, or guidelines and regulations issued by statutory authorities. The company has been advised that this approval does not constitute approval under any other Act, Regulation, rule, or bye-laws, and that separate approvals from concerned departments of the exchange must be sought wherever applicable. The disclosure was signed by Sonal Seth, Company Secretary and Compliance Officer, on May 09, 2026, from New Delhi.
Historical Stock Returns for Sat Kartar Life
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.00% | +2.71% | +21.47% | +5.37% | +43.17% | +24.51% |
How might the conversion of warrants across two tranches impact Sat Kartar Life Limited's share dilution and existing shareholders' equity stake in the near term?
What strategic business objectives is Sat Kartar Life Limited likely pursuing with the capital raised through this preferential warrant conversion, particularly given its recent rebranding from Sat Kartar Shopping Limited?
How could potential non-compliance by allottees with SEBI ICDR Regulation 167(6) trading restrictions affect the company's timeline for final listing approval and stock price stability?





























